Aivo Biosciences is pleased to announce its participation in the 2025 BIO International Convention, the world’s largest biotechnology industry gathering, taking place June 16–19 in Boston, MA.

During the convention, Aivo’s leadership team will meet with prospective partners to explore collaboration opportunities focused on the development and commercialization of its lead product candidate — a first-in-class, allosteric muscarinic receptor agonist. This novel compound demonstrates superior potency, efficacy, selectivity, and safety compared to existing therapies and is currently advancing toward IND-enabling studies.

To connect with Aivo during BIO 2025, please request a meeting via the BIO One-on-One Partnering™ system or reach out through the contact form on our website.